{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:13:18Z","timestamp":1769307198906,"version":"3.49.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/fbp.0b013e3282eff0a9","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:49:06Z","timestamp":1236210546000},"page":"591-600","source":"Crossref","is-referenced-by-count":28,"title":["Acute anorectic response to cannabinoid CB1 receptor antagonist\/inverse agonist AM 251 in rats: indirect behavioural mediation"],"prefix":"10.1097","volume":"18","author":[{"given":"Amy J.","family":"Tallett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0022-3565(25)20781-9","article-title":"\u0394-9-Tetrahydrocannabinol: studies on precipitated and abrupt withdrawal","volume":"278","author":"Aceto","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/h0077040","article-title":"Cholecystokinin elicits the complete behavioral sequence of satiety in rats","volume":"89","author":"Antin","year":"1975","journal-title":"J Comp Physiol Psychol"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s002130050326","article-title":"Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors","volume":"132","author":"Arnone","year":"1997","journal-title":"Psychopharmacology"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/13543784.11.9.1189","article-title":"Anti-obesity drug development","volume":"11","author":"Bays","year":"2002","journal-title":"Expert Opin Invest Drugs"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0361-9230(85)90004-8","article-title":"Behavioural structure and mechanisms of anorexia: calibration of normal and abnormal inhibition of eating","volume":"15","author":"Blundell","year":"1985","journal-title":"Brain Res Bull"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0031-9384(04)00302-6","article-title":"Cannabinoid (CB)1 receptor antagonist, AM251, causes a sustained reduction of daily food intake in the rat","volume":"82","author":"Chambers","year":"2004","journal-title":"Physiol Behav"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.bjp.0706439","article-title":"AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion","volume":"147","author":"Chambers","year":"2006","journal-title":"Brit J Pharmacol"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2003.12.004","article-title":"Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist namefene on food intake in mice","volume":"999","author":"Chen","year":"2004","journal-title":"Brain Res"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-6147(00)01664-3","article-title":"Pharmacotherapy of obesity: targets and perspectives","volume":"22","author":"Chiesi","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(00)00105-4","article-title":"Anti-obesity drugs: a critical review of current therapies and future opportunities","volume":"89","author":"Clapham","year":"2001","journal-title":"Pharmac Ther"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.2001.01294.x","article-title":"Drug treatment of obesity: from past failures to future successes?","volume":"51","author":"Collins","year":"2001","journal-title":"Brit J Clin Pharmacol"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"L113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoids antagonist SR141716A","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0022-3565(24)37499-3","article-title":"CB1 receptor antagonist precipitates withdrawal in mice exposed to \u0394-9-tetrahydrocannabinol","volume":"285","author":"Cook","year":"1998","journal-title":"J Pharmacol Exper Ther"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ijo.0802250","article-title":"Endogenous cannabinoid system as a modulator of food intake","volume":"27","author":"Cota","year":"2003","journal-title":"Int J Obesity and Related Metab Disord"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","article-title":"Cannabinoids, opioids and eating behavior: the molecular face of hedonism?","volume":"51","author":"Cota","year":"2006","journal-title":"Brain Res Revs"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in na\u00efve mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J Neural Transm"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"De Fonseca","year":"1997","journal-title":"Science"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Molec Pharmacol"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2003.10.012","article-title":"Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist\/inverse agonist SR141716A","volume":"483","author":"De Vry","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"DiMarzo","year":"2005","journal-title":"Nat Neurosci"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"DiMarzo","year":"1998","journal-title":"Trends Neurosci"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1530-0277.2001.tb02209.x","article-title":"Effects of SR141716A on ethanol and sucrose self-administration","volume":"25","author":"Freedland","year":"2001","journal-title":"Alcoholism: Clin Exper Res"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(96)00279-8","article-title":"123I-labeled AM251: a radioligand which binds in vivo to mouse brain cannabinoid CB1 receptors","volume":"307","author":"Gatley","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"L191","DOI":"10.1016\/S0024-3205(97)00690-5","article-title":"Binding of the non-classical cannabinoid CP 55\u2009940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors","volume":"61","author":"Gatley","year":"1997","journal-title":"Life Sci"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1471-4159.1998.70010417.x","article-title":"Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo","volume":"70","author":"Gatley","year":"1998","journal-title":"J Neurochem"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol Psychiat"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00001756-199507100-00015","article-title":"The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat","volume":"6","author":"Gueudet","year":"1995","journal-title":"NeuroReport"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","article-title":"Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake","volume":"61","author":"Halford","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"R30-2-20210202","first-page":"283","article-title":"The psychopharmacology of appetite: targets for potential anti-obesity agents","volume":"3","author":"Halford","year":"2003","journal-title":"Current Med Chem: CNS Agents"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence","volume":"15","author":"Haller","year":"2004","journal-title":"Behav Pharmacol"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","article-title":"Low-dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice","volume":"392","author":"Hao","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(03)01343-8","article-title":"Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice","volume":"462","author":"Hildebrandt","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2004.01.009","article-title":"Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats","volume":"81","author":"Ishii","year":"2004","journal-title":"Physiol Behav"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbr.2004.07.012","article-title":"Anorexia and weight loss in male rats 24\u2009h following single dose treatment with orexin-1 receptor antagonist SB-334867","volume":"157","author":"Ishii","year":"2005","journal-title":"Behav Brain Res"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0091-3057(01)00647-5","article-title":"Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by \u0394-9-THC and other cannabinoids","volume":"71","author":"Janoyan","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0091-3057(02)00938-3","article-title":"Interactions between the CB1 receptor agonist \u03949\u2013THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisitied","volume":"73","author":"J\u00e4rbe","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0091-3057(03)00168-0","article-title":"The cannabinoid receptor antagonist SR-141716 does not readily antagonise open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats","volume":"75","author":"J\u00e4rbe","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008877-200411000-00008","article-title":"(\u2212)-Adamantyl-\u03948-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open field behaviors and antagonism by SR-141716 in rats","volume":"15","author":"J\u00e4rbe","year":"2004","journal-title":"Behav Pharmacol"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pbb.2006.08.006","article-title":"Effects of CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats","volume":"85","author":"J\u00e4rbe","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.physbeh.2006.10.003","article-title":"Effect of \u03949-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test","volume":"90","author":"Jarrett","year":"2007","journal-title":"Physiol Behav"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008877-200509000-00004","article-title":"Endocannabinoids in the regulation of appetite and body weight","volume":"16","author":"Kirkham","year":"2005","journal-title":"Behav Pharmacol"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1079\/095442201108729141","article-title":"Endogenous cannabinoids and appetite","volume":"14","author":"Kirkham","year":"2001","journal-title":"Nutrition Res Rev"},{"key":"R45-2-20210202","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J Med Chem"},{"key":"R46-2-20210202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA 561","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"R47-2-20210202","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200312000-00002","article-title":"The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats","volume":"14","author":"McLaughlin","year":"2003","journal-title":"Behav Pharmacol"},{"key":"R48-2-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00213-005-2171-0","article-title":"The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats","volume":"180","author":"McLaughlin","year":"2005","journal-title":"Psychopharmacology"},{"key":"R49-2-20210202","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2006.02.022","article-title":"Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist\/inverse agonist AM 1387","volume":"83","author":"McLaughlin","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"R50-2-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"R51-2-20210202","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1517\/13543776.16.10.1405","article-title":"Latest advances in cannabinoid receptor antagonists and inverse agonists","volume":"16","author":"Muccioli","year":"2006","journal-title":"Expert Opin Ther Patents"},{"key":"R52-2-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"R53-2-20210202","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2006.03.029","article-title":"Antiobesity effects of the novel in-vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-trazole-LH21","volume":"51","author":"Pavon","year":"2006","journal-title":"Neuropharmacology"},{"key":"R54-2-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neural antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sci"},{"key":"R55-2-20210202","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(01)00130-9","article-title":"The endocannabinoid nervous system: unique opportunities for therapeutic intervention","volume":"90","author":"Porter","year":"2001","journal-title":"Pharmac Ther"},{"key":"R56-2-20210202","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","article-title":"SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats","volume":"13","author":"Rodgers","year":"2001","journal-title":"Eur J Neurosci"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0143-4179(02)00085-9","article-title":"Orexins and appetite regulation","volume":"36","author":"Rodgers","year":"2002","journal-title":"Neuropeptides"},{"key":"R58-2-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00008877-200509000-00013","article-title":"Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na\u00efve and plus-maze-experienced mice","volume":"16","author":"Rodgers","year":"2005","journal-title":"Behav Pharmacol"},{"key":"R59-2-20210202","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-3565(24)37424-5","article-title":"Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression","volume":"285","author":"Rubino","year":"1998","journal-title":"J Pharmacol Exper Ther"},{"key":"R60-2-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0304-3959(02)00401-3","article-title":"Cannabinoid agonists attenuate capsaicin-induced responses in human skin","volume":"102","author":"Rukwied","year":"2003","journal-title":"Pain"},{"key":"R61-2-20210202","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","article-title":"Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice","volume":"14","author":"Shearman","year":"2003","journal-title":"Behav Pharmacol"},{"issue":"4","key":"R62-2-20210202","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1016\/S0924-977X(03)92272-3","article-title":"The effects of cannabinoid CB1 receptor antagonist AM 251 on locomotor\/exploratory behaviour and body weight in mice","volume":"13","author":"Slais","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"R63-2-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2005.01.007","article-title":"Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibres and adnexal structures in the human skin","volume":"38","author":"St\u00e4nder","year":"2005","journal-title":"J Derm Sci"},{"key":"R65-2-20210202","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pbb.2006.06.001","article-title":"The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake","volume":"84","author":"Thornton-Jones","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"R66-2-20210202","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2174\/092986706778201512","article-title":"Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation","volume":"13","author":"Tucci","year":"2006","journal-title":"Current Med Chem"},{"key":"R67-2-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2003.10.035","article-title":"Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats","volume":"354","author":"Verty","year":"2004","journal-title":"Neurosci Letts"},{"key":"R68-2-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-002-1384-8","article-title":"Preferential effects of the cannabinoids CB1 receptor antagonist, SR141716, on food intake and body weight gain of obese (fa\/fa) compared to lean Zucker rats","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology"},{"key":"R70-2-20210202","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/S0006-8993(02)04274-9","article-title":"Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats","volume":"967","author":"Werner","year":"2003","journal-title":"Brain Res"},{"key":"R71-2-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br J Pharmacol"},{"key":"R72-2-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology"},{"key":"R73-2-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","article-title":"Observational analysis of feeding induced by delta(9)-THC and anandamide","volume":"76","author":"Williams","year":"2002a","journal-title":"Physiol Behav"},{"key":"R74-2-20210202","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of \u03949-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"Williams","year":"2002b","journal-title":"Pharmacol Biochem Behav"},{"key":"R75-2-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2006.07.018","article-title":"SR 141716 (rimonabant) precipitates withdrawal in marijuana-dependent mice","volume":"85","author":"Wilson","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"R76-2-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pbb.2003.10.015","article-title":"Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice","volume":"77","author":"Zhou","year":"2004","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008877-200711000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:56:36Z","timestamp":1738976196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-200711000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0b013e3282eff0a9","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}